Skip to main content

Market Overview

Cara Therapeutics (NASDAQ: CARA)

12.44 0.00 (0.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
4/29/21NeedhamMaintainsBuy26.0
5/19/20Cantor FitzgeraldReiteratesOverweight40.0
4/22/20WedbushMaintainsOutperform870.0
4/22/20Cantor FitzgeraldReiteratesOverweight34.0
7/30/19Piper JaffrayMaintainsOverweight39.0
5/29/19H.C. WainwrightMaintainsBuy28.0
5/29/19NeedhamMaintainsBuy35.0
2/06/19JefferiesAssumesBuy22.0
1/15/19Bank of AmericaInitiates Coverage OnNeutral19.0
9/21/18Cantor FitzgeraldInitiates Coverage OnOverweight27.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter